The Ministry of Commerce and Industry, under the Department for Promotion of Industry and Internal Trade, has introduced draft amendments to the Patents Rules, 2003. These drafts detail various changes proposed by the Central Government, anchored on section 159 of the Patents Act, 1970. The government seeks to amend the …
Mumbai: In a landmark decision that could set a precedent on how life-saving drugs under patents can be made affordable, the government has allowed a domestic company, Natco Pharma, to manufacture a copycat version of Bayer’s patented anti-cancer drug, Nexavar, bringing down its price by 97 %.. In the first-ever …
In recent years, patenting has been considered one of the major drivers for enhancing national competitiveness and most of the advanced countries have been more actively enforcing patent protection. However, the indicators proposed in previous studies have not been able to deal adequately with the various dimensions of patenting, rather …
This paper reviews theoretical and empirical literature that originated predominantly during and after TRIPS, focusing on the influence of changes in patent protection on developing countries. Previous studies identify two channels of gain for developing countries, from strong patent rights. Firstly, the promotion channel whereby, patent rights affect innovativeness of …
Sustainable agriculture and healthy nutrition are high on the social agenda. Work is now being done to face both challenges, often with measurable success. However, huge changes are still needed and some problems have even been exacerbated. Although agriculture and nutrition are closely linked, both issues are often dealt with …
The newly established Lala Lajpat Rai University of Veterinary and Animal Sciences, Hisar, has been granted a patent by the Government of India for commercial production for the “Urea Detection in Milk” technology developed by its Veterinary Public Health and Epidemiology, College of Veterinary Sciences for testing Urea in milk. …
Your data on changing stock prices for five pharmaceutical companies from 1997 to 2010 (Nature 480, 16–17; 2011) erroneously indicate a 39% drop in aggregated share value, when in fact it would have risen by 82% (see Correction, Nature 480, 425; 2011). The error was due mainly to the selection …
Reed Beall and Randall Kuhn describe their findings from an analysis of use of compulsory licenses for pharmaceutical products by World Trade Organization members since 1995. Original Source
The present study tries to explore the factors that influence the growth, performance, and development of IPR attitude of small and medium-sized enterprises (SMEs) in the manufacturing sector of Punjab. The aim of the present research is to examine the technology management strategies of manufacturing SMEs, primarily on the basis …
The very nature of traditional Chinese medicine (TCM) poses serious challenges in patenting intellectual property. Unlike modern medicines, which are based on newly discovered, developed or isolated chemical compounds, TCM prescriptions typically consist of mixtures of well-known plant or animal extracts. Moreover, these recipes are public knowledge, having been recorded …
Cholesterol Drug Hits US Stores The Day Pfizer Loses Patent Protection Mumbai: India’s largest drug company, Ranbaxy, which had been chasing a dream for years to launch the first generic version of world’s top-selling medicine Lipitor in the US, has finally succeeded—and, that too, as per schedule. Ending months of …
Lipitor goes off patent today, but Pfizer may’ve queered pitch for clones, impacting Ranbaxy-led Indian pharma Indian pharma companies’ quest to make millions from the sale of copycat versions of blockbuster drugs may turn out to be a flop show as innovative companies raise defences to protect their turf. The …
Now that “neemania” has gripped scientists in the West and neem (Azadirachta indica) is being hailed as the wonder tree that can solve global problems from locust swarms to AIDS, Indian scientists are jumping onto the bandwagon. After Western scientists proved that neem-based pesticides are safer than synthetic ones such …
Tiered pricing - the concept of selling drugs and vaccines in developing countries at prices systematically lower than in industrialized countries - has received widespread support from industry, policymakers, civil society, and academics as a way to improve access to medicines for the poor. We carried out case studies based …
The National Pharmaceuticals Pricing Policy 2011 presently seeks to limit itself to the central objective of promulgating the principles for pricing of Essential Drugs as laid down in the “National List of Essential Medicines ‐ 2011” as declared by the Ministry of Health and Family Welfare, Government of India vide …
Last week just as Swiss pharmaceuticals giant Novartis was set to begin its final arguments in the Supreme Court against the rejection of a patent for its cancer drug Glivec (see ‘Evergreen Novartis’, Down To Earth, September 1-15) there were two swift and stunning developments. A letter was written by …
The biotechnology industry has had its share of woes, but so far 'patent trolls' have not numbered among them. These companies, which profit by legally enforcing patents they own rather than developing products, may benefit from a 31 August ruling at a US federal court of appeal in Washington DC.
Monsanto Co., the world's largest seed company, has prevailed in another lawsuit against a U.S. farmer, earning a ruling from a federal appeals court that protects Monsanto's interests even when its patented seeds are sold in a mix of undifferentiated "commodity" seeds. The U.S. Court of Appeals for the Federal …
A scientist from city-based National Chemical Laboratory (NCL), Dattatraya H Dethe, has been selected for the Organisation of Pharmaceutical Producers of India (OPPI) Young Scientist award 2011 for his research work in the area of pharmaceutical sciences. The award, consisting of a memento, a citation and a cash prize, will …
For sheer persistence you have to hand it to Novartis. Ever since its blood cancer drug Glivec was refused a patent in 2006, the Swiss multinational has been fighting India’s patent law, or at least a crucial section of it, with the patent authorities and in the courts. With case …
